PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-12885 | IT And Telecommunication
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Pharmaceutical Contract Development and Manufacturing Organization Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET
7.1 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Catalent
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Recipharm
16.3 Jubilant Life Sciences
16.4 Patheon Inc
16.5 Boehringer Ingelheim
16.6 Pfizer Centreone
16.7 Aenova Group
16.8 Famar
16.9 Baxter Pharmaceutical Solutions
16.10 Lonza Group
16.11 Tesa Labtec
16.12 Tapemark
16.13 ARX LLC
16.14 Cambrex
16.15 Samsung Biologics
16.16 Fujifilm Diosynth Biotechnologies
16.17 WuXi Biologics
16.18 Center for Breakthrough Medicines (CBM)
16.19 Siegfried AG
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Segment by Type- API Development
- Pharmaceutical Manufacturing
Segment by Application
- Large Enterprise
- SME
Companies
Catalent
Recipharm
Jubilant Life Sciences
Patheon Inc
Boehringer Ingelheim
Pfizer Centreone
Aenova Group
Famar
Baxter Pharmaceutical Solutions
Lonza Group
Tesa Labtec
Tapemark
ARX LLC
Cambrex
Samsung Biologics
Fujifilm Diosynth Biotechnologies
WuXi Biologics
Center for Breakthrough Medicines (CBM)
Siegfried AG
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.